New MRI dye could help detect pancreatic cancer early

NCT ID NCT05873699

Terminated Diagnosis Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 5 times

Summary

This pilot study tests whether a special MRI dye called hyperpolarized 13-C-pyruvate can help doctors tell the difference between harmless and dangerous pancreatic cysts. About 20 adults with pancreatic cysts who are scheduled for surgery will receive the dye and have an MRI scan. The goal is to see if the dye is safe and if it can improve detection of high-risk cysts before surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hyperpolarized 13-C-pyruvate (a special MRI dye given by injection)
What this could lead to: If it works, this could help doctors better identify which pancreatic cysts are dangerous and need surgery, avoiding unnecessary operations.
What could go wrong: This is a very early, small pilot study (20 people) focused on safety and imaging feasibility. The dye may not clearly distinguish cyst types, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CYST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic tumor of the pancreas Pancreatic Cyst

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CYST

Contacts and locations

Locations

M D Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.